Targeted Therapy in Ovarian Cancer
نویسندگان
چکیده
Ovarian cancer (OC) is associated with a dismal prognosis and lack of curative treatment. Increased understanding OC biology has led to the development several targeted therapies, including antiangiogenic agents poly(ADP-ribose) polymerase (PARP) inhibitors. Cell cycle inhibitors endocrine therapy such as selective estrogen receptor down regulators are currently under development. In this article, we provide an overview current emerging therapies in OC.
منابع مشابه
Targeted Therapy in Ovarian Cancer
Ovarian cancer is the most common cause of mortality of tumors from gynecologic origin and is often diagnosed after patients have already progressed to advanced disease stage. The current standard of care for treatment of ovarian cancer includes cytoreductive surgery followed by adjuvant chemotherapy. Unfortunately, many patients will recur and ultimately die from their disease. Targeted therap...
متن کاملTargeted cancer therapy: review article
Cancer is one of the most dangerous health problems of today modern societies which has an increasing rate especially in developing countries. There are many diverse ongoing treatment attempts trying to defeat cancer. Despite that, scientists have been unable to find a permanent cure for this disease. In many cases although there is a successful first response in patients, cancer cells are fina...
متن کاملOvarian Cancer: Opportunity for Targeted Therapy
Ovarian cancer is a common cause of cancer mortality in women with limited treatment effectiveness in advanced stages. The limitation to treatment is largely the result of high rates of cancer recurrence despite chemotherapy and eventual resistance to existing chemotherapeutic agents. The objective of this paper is to review current concepts of ovarian carcinogenesis. We will review existing hy...
متن کاملMolecular Targeted Drug Therapy of Ovarian Cancer
Molecular targeted therapy as a new means of cancer therapy targeting molecular pathological abnormalities of cancer, the use of target binding ligand and receptor can effectively improve drug lethal to tumor cells while reducing adverse effects on normal tissues and organs, it has been gradually used in clinical treatment. In the treatment of ovarian cancer in comparison with conventional trea...
متن کاملEpithelial Ovarian Cancer: Focus on Targeted Therapy
Over the past five decades ovarian cancer has been of considerable interest to clinical cancer investigators due to the fact that it is among the most chemosensitive of all solid tumors [1]. Unfortunately, despite the advances in the chemotherapeutic management of this malignancy, the large majority of patients ultimately recur, progress, and ultimately die as a direct result of complications o...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Healthbook TIMES
سال: 2021
ISSN: ['2673-2106', '2673-2092']
DOI: https://doi.org/10.36000/hbt.oh.2021.08.033